Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
Moodys
Fish and Richardson
Johnson and Johnson
Merck
Deloitte
AstraZeneca
Federal Trade Commission

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020919

« Back to Dashboard

NDA 020919 describes GEODON, which is a drug marketed by Pfizer and Pfizer Inc and is included in three NDAs. It is available from seven suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the GEODON profile page.

The generic ingredient in GEODON is ziprasidone mesylate. There are twenty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ziprasidone mesylate profile page.
Summary for 020919
Tradename:GEODON
Applicant:Pfizer
Ingredient:ziprasidone mesylate
Patents:0
Therapeutic Class:Antipsychotics
Bipolar Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020919
Suppliers and Packaging for NDA: 020919
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919 NDA Roerig 0049-1203 N 0049-1203-10
GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919 NDA Roerig 0049-3920 N 0049-3920-83

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAMUSCULARStrengthEQ 20MG BASE/ML
Approval Date:Jun 21, 2002TE:RLD:Yes

Expired US Patents for NDA 020919

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002 ➤ Sign Up ➤ Sign Up
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002 ➤ Sign Up ➤ Sign Up
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002 ➤ Sign Up ➤ Sign Up
Pfizer GEODON ziprasidone mesylate INJECTABLE;INTRAMUSCULAR 020919-001 Jun 21, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
QuintilesIMS
Fuji
Farmers Insurance
Chinese Patent Office
AstraZeneca
Moodys
Covington
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.